Select Page

TRANSFORMING CARE FOR PATIENTS IN NEED

Using next-generation enzyme compounds Oxidien develops treatments for

secondary hyperoxaluria to ultimately prevent kidney stone disease.

We’re updating our site to better serve our visitors. Please visit again soon to see what’s new, or fill out the form below and our team will be in touch with you.

Download Oxidien’s Latest Non-confidential Deck

  • Enter your Email to download Oxidien’s Latest Non-confidential Deck

Oxidien Pharmaceuticals

405 Waltham St. #327
Lexington, MA 02421

Phone